Angiotensin-(1–7) treatment mitigates right ventricular fibrosis as a distinctive feature of diabetic cardiomyopathy
Panpan Hao(Ningxia Medical University), Yun Zhang(Baylor College of Medicine), Kai Zhang(Nanjing Medical University), Cheng Zhang(Shanghai Sixth People's Hospital), Jianmin Yang(Qilu Hospital of Shandong University), Mingxiang Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Yuguo Chen(Qilu Hospital of Shandong University)
American Journal of Physiology-Heart and Circulatory Physiology
February 28, 2015
Cited by 52
Related Papers
Traditional Chinese Medicine for Cardiovascular Disease
|Journal of the American College of Cardiology|2017|592
Regulatory T cells in cardiovascular diseases
|Nature Reviews Cardiology|2015|410
Gut microbiota dysbiosis promotes age-related atrial fibrillation by lipopolysaccharide and glucose-induced activation of NLRP3-inflammasome
|Cardiovascular Research|2021|270
Angiotensin IV attenuates diabetic cardiomyopathy <i>via</i> suppressing FoxO1-induced excessive autophagy, apoptosis and fibrosis
|Theranostics|2021|150
Traditional Chinese medication for cardiovascular disease
|Nature Reviews Cardiology|2014|134